Oruka Therapeutics, Inc. - Common Stock ORKA 深 沪
已收盘 09-18 16:00:00 美东时间
25.38
-1.090
-4.12%
华盛通- 最 高26.405
- 今 开25.60
- 成交量 2.33万股
- 最 低 25.16
- 昨 收 26.47
- 总市值 8.88亿
- 52周最高 34.524
- 市盈率 静 --
- 换手率 0.07%
- 52周最低 -0.636
- 委 比 81.08%
- 总股本 3499.86万
- 历史最高 5922.804
- 量 比 0.34
- 振 幅 4.70%
- 历史最低 -0.636
- 每 手 1
- 风险率 10.05%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Innovative Antibody Engineering Positions Oruka Therapeutics for Market Success
Oruka Therapeutics (ORKA) has received a new Buy rating, initiated by TD Cowen ...
09-16 17:45
Oruka Therapeutics Secures $200M to Advance Skin Disease Treatments
Oruka Therapeutics ( ($ORKA) ) just unveiled an update. Oruka Therapeutics, Inc...
09-14 04:28
Oruka Therapeutics announces $200M private financing
Oruka Therapeutics (NASDAQ:ORKA) is looking to raise approximately $200M from a private investment in public equity (PIPE) financing. Oruka is selling 5.6M shares of its common stock at $23 each, 2,43...
09-12 20:08
美股周涨跌榜 | 业绩大放异彩！蔚来周涨逾24%，Q3交付指引超预期；疫苗公司Vaxcyte周飙涨38%
业绩大放异彩！蔚来周涨逾24%，Q3交付指引超预期；安全性比肩辉瑞！疫苗公司Vaxcyte周飙涨38%；FYBR周涨23%，Verizon欲斥现金200亿美元收购>>
09-07 11:41
Oruka Therapeutics Completes Merger with ARCA Biopharma, Begins Trading Under ORKA, Appoints CRISPR CEO as Chairman
Oruka Therapeutics, Inc. ("Oruka") (NASDAQ:ORKA), a biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases, including plaque psoriasis, today announced
09-03 19:06
